YLZ-F5, a novel polo-like kinase 4 inhibitor, inhibits human ovarian cancer cell growth by inducing apoptosis and mitotic defects
Zhu, Yongxia, Liu, Zhihao, Qu, Yanling, Zeng, Jun, Yang, Meiqin, Li, Xiaoyi, Wang, Zhaodi, Su, Junxiang, Wang, Xueqin, Yu, Luoting, Wang, YueJournal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-020-04098-w
Date:
June, 2020
File:
PDF, 4.98 MB
2020